GlassScriptPhysician profile
Morgan Broussard
NPI 1063946689
$1,725.74
in general payments reported to CMS, 2019-2025
16 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.63 · 2022: $219 · 2023: $683 · 2024: $478 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $658.15 | 2022-2025 | |
| Myriad Women'S Health, INC. | $245.20 | 2023 | Myrisk |
| Exeltis, USA INC. | $227.04 | 2023-2025 | Slynd |
| Abbvie INC. | $154.50 | 2021-2024 | Orilissa, Lo Loestrin Fe, Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $105.66 | 2022-2025 | |
| Therapeuticsmd, INC. | $71.74 | 2021-2022 | |
| Gynesonics, INC. | $49.75 | 2022 | |
| Millicent US INC | $38.97 | 2025 | Intrarosa, Femlyv |
| Coopersurgical, INC. | $38.90 | 2022-2023 | Paragard T 380a |
| Organon LLC | $36.26 | 2024 | |
| Evofem Biosciences, INC. | $24.15 | 2024-2025 | Solosec, Phexx, Phexxi |
| Sumitomo Pharma America, INC. | $18.22 | 2024 | Myfembree |
| Pfizer INC. | $15.54 | 2022 | |
| Renovia INC | $15.26 | 2021 | |
| Sanara Medtech INC. | $13.95 | 2024 | Celleraterx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $12.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.